Jan Törnell

Jan Törnell

MD, PhD / Chairman of the Board

Jan Törnell has extensive international experience from managerial positions within life science, for example as Vice President of Global Strategy at AstraZeneca Oncology & Infection. Dr Törnell has further held positions as professor at the Sahlgrenska Academy. He is chairman of the board of Lidds AB and Glactone Pharma AB, a board member of Abliva AB and Innotext AB, where he also serves as CEO, and deputy board member of Lidds Pharma AB. Dr Törnell also works as an adviser in various pharmaceutical projects.

Position: Chairman of the Board

Elected: May 2022

Year of birth: 1960

Holdings: 5000 shares*

Independent in relation to the company and its management: Yes

Independent in relation to larger shareholders: Yes

*Own or related natural or legal person holding shares and other financial instruments in the company. Holdings as of May 19, 2022.

 

Three quick questions to Jan Törnell >>